Authors: E. Drbohlavová 1A; J. Gumulec 2A; A. Buliková 3A; P. Ďulíček 4A; J. Hirmerová 5AB; R. Malý 6AB; J. Václavík 7C; P. Kessler 8D; M. Kacerovský 9E; M. Macek 10F; P. Calda 11F Authors‘ workplace: Oddělení klinické hematologie Krajské nemocnice Liberec a. s. 1; Klinika hematoonkologie LF OU a FN Ostrava 2; Oddělení klinické hematologie, LF MU a FN Brno 3; IV. interní hematologická klinika FN Hradec Králové 4; II. interní klinika LF UK a FN Plzeň 5; I. interní kardioangiologická klinika FN Hradec Králové 6; Interní a kardiologická klinika FN Ostrava 7; Oddělení hematologie a transfuziologie, Nemocnice Pelhřimov 8; Perinatologické centrum intenzivní péče Krajské zdravotní – Nemocnice Most 9; Ústav biologie, a lékařské genetiky, 2. LF UK a FN Motol 10; Klinika gynekologie, porodnictví a neonatologie 1. LF UK a VFN v Praze 11 Published in: Transfuze Hematol. dnes,31, 2025, No. Ahead of Print, p. 1-6. Category: Best Practices doi: https://doi.org/10.48095/cctahd2025prolekare.cz14
An interdisciplinary opinion of six professional societies summarizes the rules of antithrombotic prophylaxis in women during pregnancy, childbirth and the puerperium. This is the period when women are at risk of thromboembolic disease, which significantly affects maternal mortality and morbidity. The text follows earlier published recommendations (M. Penka, T. Binder, P. Dulíček. Antithrombotic measures of pregnant women according to the risk of thromboembolic disease (TEN) – recommended guideline. Ceska Gynekol 2013; 78 (Suppl): 34 – 36 and the consensus statement of the Sections of the CGSC of the Czech Medical Association of J. E. Purkyně Antithrombotic management of women during pregnancy, delivery and pospartum: part B – inpatient care. Collection of recommended practices 3/ 2022) and is supplemented with recent information based on established international recommendations. The aim of the recommendations is to standardise and coordinate care by all professionals involved. For clarity, the text is divided into short paragraphs, tables and graphs.
thrombophilia – Venous thromboembolism – risk factors – antithrombotic drugs
Don‘t have an account? Create new account
Enter the email address that you registered with. We will send you instructions on how to set a new password.
